Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof

Details for Australian Patent Application No. 2004235971 (hide)

Owner Novartis AG

Inventors Seiler, Max Peter

Agent Davies Collison Cave

Pub. Number AU-B-2004235971

PCT Pub. Number WO2004/099206

Priority 0310867.7 12.05.03 GB

Filing date 11 May 2004

Wipo publication date 18 November 2004

Acceptance publication date 3 April 2008

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/099206 Priority application(s): WO2004/099206

3 April 2008 Application Accepted

  Published as AU-B-2004235971

10 July 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Jun 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

31 July 2008 Standard Patent Sealed

4 December 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Jun 2008

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004235974-Method of detecting proBNP with a monoclonal antibody binding to the amino acid 41-46

2004235967-Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them